Navigation Links
Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Date:11/1/2010

50 was discovered as part of an alliance between Abbott and Enanta and is being developed with low-dose ritonavir, which enhances the pharmacokinetic properties of ABT-450, allowing for once-daily dosing. This Phase 2 study also evaluated ABT-333 and ABT-072, two of Abbott's internally discovered compounds that are part of the company's ongoing non-nucleoside polymerase inhibitor development program. The study findings for these two compounds have been submitted for presentation at a future scientific meeting.

About the Hepatitis C VirusHepatitis C is a liver disease affecting more than 180 million people worldwide.  The virus is primarily spread through direct contact with the blood of an infected person.  HCV increases a person's risk of developing chronic liver disease, cirrhosis, liver cancer and death.

Liver disease associated with HCV infection is growing rapidly, and current therapies only cure about half of patients with the genotype 1 form of the virus. Specifically targeted antiviral therapies for HCV, such as protease inhibitors and non-nucleoside polymerase inhibitors, may have the potential to increase the proportion of patients in whom the virus can be eradicated.

About Ritonavir The use of NORVIR® (ritonavir) with ABT-450 for the treatment of HCV is investigational.

NORVIR is in a class of medicines called the HIV protease (PRO-tee-ase) inhibitors. NORVIR is used in combination with other anti-HIV medicines to treat people with human immunodeficiency virus (HIV) infection. NORVIR is for adults and for children age greater than 1 month and older.

NORVIR does not cure HIV infection or AIDS and does not reduce the risk of passing HIV to others. People taking NORVIR may still get opportunistic infections or other conditions that happen with HIV infection. Some of these conditions are pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC) infections.

People should
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Abbott Again Recognized for Environmental Initiatives in Illinois
2. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
3. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
6. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
7. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
8. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
9. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
10. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
11. Abbott Declares 347th Consecutive Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , and DURHAM, N.C. , July ... today announced its acquisition of assets related to the ... PFE ) that had previously been obtained as part ... also acquired all of Pfizer,s rights to the "Icagen" ... brand and will provide comprehensive services for ion channel ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
(Date:7/2/2015)... 2, 2015  The Commission for Certification in ... an organization that represents pharmacists in acute and ... continuing education for recertification of Certified Geriatric Pharmacists.  ... programs for this purpose.  ASHP will join the ... for the CCGP Professional Development Program. ...
Breaking Medicine Technology:Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... Food and Drug Administration for its Abbreviated New ... Powder for Solution. Perrigo is expecting to begin ... under store brand labels and is comparable to ...
... BATESVILLE, Ind., Oct. 6 Hill-Rom Holdings, Inc. (NYSE: ... has unanimously approved enhancements to the Company,s corporate ... of majority voting in uncontested elections. The ... for a majority voting standard for the election of directors ...
Cached Medicine Technology:Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350 2Hill-Rom Announces Corporate Governance Enhancements 2Hill-Rom Announces Corporate Governance Enhancements 3Hill-Rom Announces Corporate Governance Enhancements 4
(Date:7/2/2015)... ... July 02, 2015 , ... The American ... introduction of the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, ... this Act seeks to decrease drug overdose – especially of heroin and opioid ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the ... was alone. He sat down to write his first poem, and three years later he ... that was special and worth sharing with the world. "I have always believed that the ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Global leader and ... in compression socks designed for men. , For style that’s quick on its ... daily routine. This is great news for men everywhere because a simple change in ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... Healthcare Delivery Coalition met for the late June Web-based session, the speakers discussed ... reimbursement schemes and managing high-risk patients through coordinated care. , During the session, ...
(Date:7/2/2015)... ... 02, 2015 , ... Facial plastic surgery is about more ... an art and science that goes into successful facial reconstruction and contouring. Dr. ... and lives of more than 2,500 satisfied facelift and neck lift patients alone. ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... of aggressive prostate cancer is an elevated rate of increase ... study. The study found that a pre-treatment rate of ... was strongly associated with a high risk of death from ... factor than any other single high-risk indicator, such as a ...
... AMO Complete Moisture Plus Multi-Purpose Solution. For an ongoing government ... to an increased risk of Acanthamoeba keratitis, a rare ... cause permanent vision loss or blindness. The Centres for Disease ... of the disease occur in contact lens users. ...
... (AMSA) National President, Mr Rob Mitchell, today said expensive ... undergraduate admission testing for entry into medical school. ... students are paying as much as $1,700 to attend ... scoring well on the Undergraduate Medical Admission Test (UMAT). ...
... looking for a mate run great risks. Scientists from ... Research Institute in Panama present a new take on ... Public Library of Science. The researchers report that females ... their predators as they sequentially visit and assess potential ...
... fire ants (RIFAs), which have caused trouble in Florida ... Colonies of the tiny, highly aggressive insects have been ... recent years, have caught the attention of Virginia Tech ... increasing number of fire ant infestations. ,"Virginia ...
... neurocognitive functioning, including decision-making capabilities. ... drinking, common among college students, is associated with ... neurocognitive effects of binge drinking during young adulthood ... tend to have poorer neurocognitive functioning, including decision ...
Cached Medicine News:Health News:High Pretreatment PSA Velocity Predicts Worse Outcome 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 3Health News:Scientists Report New Take on Sexual Signaling 2Health News:Fire Ants are Emerging Nuisance for Virginians 2Health News:Fire Ants are Emerging Nuisance for Virginians 3Health News:Binge Drinking Leads to Neurocognitive Deficits Among College Students 2Health News:Binge Drinking Leads to Neurocognitive Deficits Among College Students 3
... Streck-Kleen is an enzymatic cleanser for ... Coulter® Counters. The 475ml bottle has a ... MD Series instruments that require manual addition ... is a feature of this product. The ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
... balanced electrolyte solution manufactured for use as ... sizing. Streck-Diluent III is for use on ... JS, JT, S-Plus IV, V, VI with ... 1400 and 1600. The shelf life is ...
Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The s...
Medicine Products: